The European Medicines Agency also accepted for review the Marketing Authorization Application for ozanimod for the treatment of adults with relapsing-remitting
multiple sclerosis, or RRMS, in the European Union.
Subcutaneous Ofatumumab in Patients with Relapsing-remitting
Progressive MS is divided into primary progressive MS (approximately 15% of all patients) and secondary progressive MS that follows a period of relapsing-remitting
disease course .
GA Depot is a proposed once-monthly injection for the treatment of patients with relapsing-remitting
multiple sclerosis, or RRMS.
Today, twelve drugs have been approved for the treatment of relapsing-remitting
multiple sclerosis; for the progressive types, on the other hand, only a few therapy approaches exist.
M2 EQUITYBITES-December 4, 2017-Merck passes Health Canada's approval for MAVENCLAD (Cladribine Tablets) to treat relapsing-remitting
M2 PHARMA-December 4, 2017-Merck passes Health Canada's approval for MAVENCLAD (Cladribine Tablets) to treat relapsing-remitting
Adults living with relapsing-remitting
MS may be helped by new treatment, Tecfidera, as the National Institute for Health and Care Excellence (Nice) has issued approval guidance for its use.
SAN DIEGO -- Full results of the second phase III trial of dimethyl fumarate in patients with relapsing-remitting
multiple sclerosis show that the investigational drug significantly reduced annualized relapse rates and MRI lesions over the course of 2 years.
Its effect in people with relapsing-remitting
MS (RRMS) compared with the earlier experience in those with progressing disease seems to delineate clearly the difference between the initial systemic, inflammatory disease and the subsequent progressive, degenerative disease confined within the central nervous system.
Summary: TEHRAN (FNA)- A new study for comparing the efficacy of 250 micro/g or 500 micro/g interferon beta-1b with Glatiramer acetate for treating relapsing-remitting
multiple sclerosis showed that both doses had similar clinical effects to Glatiramer acetate.